JournalsHub
.online
Find My Journal
PS

Pieter Sonneveld

Erasmus MC Cancer Institute NL

ORCID iD 0000-0002-0808-2237
1,253
Publications
76,943
Citations
126
H-Index
586
i10-Index
6.88
2yr Mean Cite
-
Cite/Paper
Data combined from OpenAlex + Semantic Scholar. OA = OpenAlex S2 = Semantic Scholar
Verify on Google Scholar

Publication & Citation Trends

Publications

0 total

Gene signature combinations improve prognostic stratification of multiple myeloma patients

W. Chng, Tae-Hoon Chung, Shaji K. Kumar, S. Usmani, Nikhil C. Munshi - Leukemia, 2016
Cited by 52 Semantic Scholar

Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial

S. Verelst, Fabian Termorshuizen, C. U. Groot, M. Schaafsma, A. Ammerlaan - Annals of Hematology, 2011
Cited by 38 Semantic Scholar

MicroRNA signatures characterize multiple myeloma patients OA

S. Corthals, S. Sun, R. Kuiper, Y. D. Knegt, A. Broyl - Leukemia, 2011
Cited by 59 Semantic Scholar

Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield OA

I. Breitkreutz, H. Lokhorst, M. Raab, B. Holt, F. Cremer - Leukemia, 2007
Cited by 74 Semantic Scholar

Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma OA

G. W. Imhoff, B. Holt, M. MacKenzie, G. J. Ossenkoppele, P. Wijermans - Leukemia, 2005
Cited by 64 Semantic Scholar

Cost determinants in aggressive non-Hodgkin's lymphoma

M. Agthoven, P. Sonneveld, L. F. Verdonck, C. U. Groot - Unknown Venue, 2005
Cited by 19 Semantic Scholar

A cost-utility analysis comparing intensive chemotherapy alone to intensive chemotherapy followed by myeloablative chemotherapy with autologous stem-cell rescue in newly diagnosed patients with stage II/III multiple myeloma; a prospective randomised phase III study.

M. Agthoven, C. Segeren, I. Buijt, C. U. Groot, B. Holt - European Journal of Cancer, 2004
Cited by 61 Semantic Scholar

Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy

Monique C. Minnema, Iris Breitkreutz, J. Auwerda, B. Holt, F. Cremer - Leukemia, 2004
Cited by 98 Semantic Scholar

Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients

H. Goldschmidt, P. Sonneveld, F. Cremer, B. Holt, P. Westveer - Annals of Hematology, 2003
Cited by 47 Semantic Scholar

Research Topics

Multiple Myeloma Research and Treatments (897) Protein Degradation and Inhibitors (409) Cancer Treatment and Pharmacology (213) Peptidase Inhibition and Analysis (208) Chronic Lymphocytic Leukemia Research (112)

Affiliations

Boston University
US 2005 - 2005
Goethe University Frankfurt
DE 2004 - 2004
European Organisation for Research and Treatment of Cancer
NL 2001 - 1998
Novartis (Switzerland)
CH 2022 - 2022
Boston Children's Hospital
US 2001 - 2001

External Profiles

OpenAlex Profile Semantic Scholar Profile ORCID Profile Google Scholar

Share Profile

Back to Researchers
Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now